These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27065000)

  • 21. Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China.
    Zhang Y; Wu P; Feng L; Yang P; Pan Y; Feng S; Qin Y; Zheng J; Puig-Barberà J; Muscatello D; MacIntyre R; Cowling BJ; Yu H; Wang Q
    Vaccine; 2017 May; 35(23):3129-3134. PubMed ID: 28456530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network.
    Puig-Barberà J; Mira-Iglesias A; Burtseva E; Cowling BJ; Serhat U; Ruiz-Palacios GM; Launay O; Kyncl J; Koul P; Siqueira MM; Sominina A;
    BMC Infect Dis; 2019 May; 19(1):415. PubMed ID: 31088481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.
    Darvishian M; Dijkstra F; van Doorn E; Bijlsma MJ; Donker GA; de Lange MM; Cadenau LM; Hak E; Meijer A
    PLoS One; 2017; 12(1):e0169528. PubMed ID: 28068386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe.
    Kissling E; Rondy M;
    Euro Surveill; 2017 Feb; 22(7):. PubMed ID: 28230524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of influenza vaccine in children in preventing influenza associated hospitalisation, 2018/19, England.
    Pebody RG; Zhao H; Whitaker HJ; Ellis J; Donati M; Zambon M; Andrews N
    Vaccine; 2020 Jan; 38(2):158-164. PubMed ID: 31648914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24.
    Pérez-Gimeno G; Mazagatos C; Lorusso N; Basile L; Martínez-Pino I; Corpas Burgos F; Batalla Rebolla N; Rumayor Zarzuelo MB; Andreu Ivorra B; Giménez Duran J; Castrillejo D; Guiu Cañete I; Huerta Huerta M; García Becerril M; Ramos Marín V; Casas I; Pozo F; Monge S; ;
    Euro Surveill; 2024 Oct; 29(40):. PubMed ID: 39364601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
    Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France.
    Souty C; Vilcu AM; Capai L; van der Werf S; Valette M; Blanchon T; Lina B; Behillil S; Hanslik T; Falchi A
    J Clin Virol; 2017 Oct; 95():1-4. PubMed ID: 28818690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.
    Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A;
    Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza epidemiology and influenza vaccine effectiveness during the 2016-2017 season in the Global Influenza Hospital Surveillance Network (GIHSN).
    Baselga-Moreno V; Trushakova S; McNeil S; Sominina A; Nunes MC; Draganescu A; Unal S; Koul P; Kyncl J; Zhang T; Kuatbayeva A; Ben-Salah A; Burtseva E; Puig-Barberà J; Díez-Domingo J;
    BMC Public Health; 2019 May; 19(1):487. PubMed ID: 31046725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14.
    Broberg E; Hungnes O; Schweiger B; Prosenc K; Daniels R; Guiomar R; Ikonen N; Kossyvakis A; Pozo F; Puzelli S; Thomas I; Waters A; Wiman Å; Meijer A
    Euro Surveill; 2016 Oct; 21(41):. PubMed ID: 27762211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
    Valenciano M; Kissling E;
    Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Pozo F; Casado I; Guevara M; Martínez-Baz I; Barricarte A; Ezpeleta C; ;
    Vaccine; 2016 Mar; 34(11):1350-7. PubMed ID: 26854911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016.
    Chambers C; Skowronski DM; Sabaiduc S; Winter AL; Dickinson JA; De Serres G; Gubbay JB; Drews SJ; Martineau C; Eshaghi A; Krajden M; Bastien N; Li Y
    Euro Surveill; 2016; 21(11):30168. PubMed ID: 27020673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.
    Thompson MG; Kwong JC; Regan AK; Katz MA; Drews SJ; Azziz-Baumgartner E; Klein NP; Chung H; Effler PV; Feldman BS; Simmonds K; Wyant BE; Dawood FS; Jackson ML; Fell DB; Levy A; Barda N; Svenson LW; Fink RV; Ball SW; Naleway A;
    Clin Infect Dis; 2019 Apr; 68(9):1444-1453. PubMed ID: 30307490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain.
    Gherasim A; Martínez-Baz I; Castilla J; Pozo F; Larrauri A;
    PLoS One; 2017; 12(6):e0179160. PubMed ID: 28614376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.